Morgan Stanley Adma Biologics, Inc. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 5,534,337 shares of ADMA stock, worth $102 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,534,337
Previous 8,599,618
35.64%
Holding current value
$102 Million
Previous $172 Million
44.79%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$344 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$335 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$274 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$208 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA5.43MShares$100 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.62B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...